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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A154and COL10A1; instead these genes are downregulated by hypoxia.
Another hypoxia-inducible factor isoform, HIF-3a, is reportedly able to
bind HIF-1a, HIF-2a, and HIF-1b (ARNT) and may inhibit their tran-
scriptional activity. Unlike HIF-1a and HIF-2a, very little is known about
the expression and function of HIF-3a in the context of chondrocyte
biology, but knockdown studies in osteosarcoma cells have implicated it
in the regulation of hypertrophy-related genes. We therefore examined
the expression of HIF-3a in chondrogenic cells at various levels of dif-
ferentiation, and tested its contribution to the HIF-2a/ARNTL-driven
transactivation of MMP13.
Methods:HIF-3amRNA (HIF3A) was quantiﬁed in human bonemarrow
mesenchymal stem cells (MSCs) and human primary articular chon-
drocytes from healthy and osteoarthritic (OA) tissue in three-dimen-
sional cultures and in human embryonic epiphyses. The normal and OA
chondrocytes and MSCs were expanded in monolayer and then redif-
ferentiated or differentiated, respectively, in pellet cultures using our
serum-free deﬁned chondrogenic medium containing dexamethasone
and TGF-b1 in hypoxic culture conditions (2% oxygen). For analysis of
HIF3A in tissues, total RNA was extracted via laser capture micro-
dissection from different zones of human embryonic growth plates.
HIF3A mRNA was quantiﬁed in cells and tissues by qPCR using Taqman
primers speciﬁc to a region shared by all known splice variants. Dual-
luciferase assays were performed using the human chondrocyte cell
line, C28/I2. Cells were transfected with pRL-TK Renilla luciferase con-
trol vector, -1602/þ20-MMP13-Luc reporter construct, and expression
vectors for HIF-2a, full-length HIF-3a (i.e. HIF-3a9), and ARNTL alone or
in combination. Transfected cells were lysed after 24 hours and ﬁreﬂy
and Renilla luciferase measured using the Dual-Luciferase Reporter
Assay System (Promega). To assess in vivo binding interactions, HEK293
cells were transiently transfected with expression vectors for ARNTL-
V5-His and HIF-3a alone or in combination and lysed after 48 hours.
Cell extracts were immunoprecipitated with anti-His antibody. SDS-
PAGE separated proteins in the immunoprecipitates were Western
blotted with anti-HIF-3a antibody (Abcam).
Results: HIF3A expression was very low in dedifferentiated healthy
human chondrocytes but signiﬁcantly increased during rediffer-
entiation (>1000-fold). By comparison, HIF3A was expressed at sig-
niﬁcantly lower levels in chondrocytes from OA joints, expressing
higher levels of COL10A1 and MMP13 when compared to healthy
counterparts. Consistent with this, HIF3A was extremely low in both
undifferentiated and chondrogenically-induced MSCs expressing very
high levels of hypertrophic genes. The inverse association of HIF3Awith
hypertrophic markers was conﬁrmed in vivo by analysis of different
zones of human embryonic growth plate cartilage: HIF3A expression
was highest in the zone containing precursor chondrocytes and lowest
in the hypertrophic zone. A functional role related to hypertrophic gene
expression was conﬁrmed by reporter gene assays. As previously
reported, co-expression of HIF-2a alone with an MMP13 reporter was
sufﬁcient to activate transcription; and co-transfection with ARNTL
enhanced HIF-2a-mediated transactivation. Co-transfection of HIF-3a
decreased the reporter activity driven by either HIF-2a alone or the
combination of HIF-2a and ARNTL. Neither HIF-3a alone nor the com-
bination of HIF-3a and ARNTL activated the reporter, indicating that the
reduction in activity caused by HIF-3a is not due simply to its weaker
transcriptional activity. Immunoprecipitation of ARNTL co-precipitated
with HIF-3a, suggesting competition for this b-subunit as a potential
mechanism for HIF-3a inhibition of MMP13 expression.
Conclusions: HIF-3a has an inverse association with hypertrophic
markers in chondrogenic cells in vitro and in vivo, and can inhibit HIF-
2a/ARNTL-mediated transactivation of MMP13. The ﬁndings presented
here lend support to the hypothesis that HIF-3a is a regulator of
chondrocyte hypertrophic terminal differentiation and suggest that it
should be examined as a potential target in cartilage pathologies.
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DIABETES-ACCELERATED CARTILAGE DEGRADATION IN
OSTEOARTHRITIS IS ASSOCIATED WITH DEFECTIVE AUTOPHAGY
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B. Carames y. yCartilage Biology Group, Rheumatology Div., INIBIC-
Complejo Hosp.ario A Coru~na, A Coru~na, Spain; zCtr. for NeuroSci. and
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Purpose: Type 2 Diabetes (T2D), a disease that causes blood glucose
levels to rise higher than normal and has an impact on insulinutilization, is an important risk factor for Osteoarthritis (OA), the most
prevalent aging-related joint disease that affects millions of people
worldwide. Although epidemiological studies suggest a strong associ-
ation between these diseases, how T2D contributes to the deterioration
of articular cartilage is still unknown. Autophagy is a central homeo-
static mechanism for cellular quality control. Several studies suggest
that autophagy is impaired both in OA and T2D, however, how diabetic
conditions inﬂuence autophagy in articular cartilage remains unex-
plored. The objective of this study is to understand the role of
autophagy in the articular cartilage function under diabetic conditions.
Methods: Human primary articular chondrocytes (HC) and a chon-
drocytic cell line (TC28a2) were cultivated in DMEM high glucose (25
mM glucose) and treated with Insulin (10, 100, 500 nM) for 2, 6 or 24
hours. LC3II levels were evaluated by Western blotting (WB) and
Inmunoﬂuorescence (IF). To explore the molecular mechanism poten-
tially involved in this effect, the phosphorylation status of Akt and the
ribosomal protein S6 (rpS6) was evaluated by WB. To further investigate
whether autophagy activation protects chondrocytes from diabetic
conditions, autophagy was induced by the mammalian target of Rapa-
mycin complex 1 (mTORC1) selective inhibitor, Rapamycin (10 mM).
Furthermore, human cartilage explants were cultivated in DMEM high
glucose and insulin (100, 500, 1000 nM) for 24 hours. Cartilage explants
were evaluated by Safranin O staining andMMP-13 and IL-1b expression
was quantiﬁed by immunohistochemistry (IHC) and WB, respectively.
Expression of LC3 and p-rpS6 was determined by WB in primary human
chondrocytes from Osteoarthritis (OA) and OA-Diabetic patients.
Results: In the presence of high glucose and insulin, autophagy was
decreased in a concentration-dependent-manner in human chon-
drocytes, as indicated by LC3II expression, the main marker of
autophagy activation (TC28-a2; p < 0.05 at 6 hours post-treatment; HC;
p < 0.01 at 24 hours post-treatment compared to untreated condition).
To investigate the mechanism by which autophagy is reduced by
insulin, Akt and rpS6 phosphorylation was analyzed. We observed a
signiﬁcant increase in p-AKT and p-rpS6 levels, suggesting that the
effect of insulin on autophagy is mediated by AKT/mTOR pathway
(TC28-a2 p < 0.05 at 6 hours; HC; p < 0.01 at 2 hours compared to
untreated condition). Furthermore, pharmacological induction of
autophagy by Rapamycin reversed insulin effects on LC3II and p-rbS6
levels (Tc28a2 and HC: p < 0.05 at 24 hours post-treatment), indicating
that autophagy induction prevents insulin-mediated autophagy
downregulation. To evaluate the impact of insulin-mediated autophagy
regulation in the context of articular cartilage biology, cartilage explants
were treated with insulin (100, 500 and 1000 nM) for 24 hours. His-
tological analysis indicated a dramatic loss of proteoglycans after
insulin treatment. The observed cartilage degradation was associated
with an increase in OA pathology biomarkers, MMP-13 and IL-1b
expression (p < 0.01 compared to untreated condition). Remarkably,
cartilage tissue from OA-diabetic patients, showed decreased LC3 and
increased p-rpS6 expression compared to non-diabetic OA patients,
indicating a defect on basal autophagy mechanisms.
Conclusions: Our ﬁndings indicate that diabetic conditions contribute
to impair autophagy in human chondrocytes and cartilage and this is
associated with increased cartilage degradation. Furthermore, diabetic
conditions decreased autophagy in cultured chondrocytes by an AKT/
mTOR-dependent mechanism. Therefore, pharmacological inter-
ventions that activate autophagy by inhibition of mTOR might protect
against T2D-associated OA in human chondrocytes. Our data also
indicate that chondrocytes from OA-diabetic patients exhibit a deﬁcient
basal autophagy. Taking together, these results suggest that impaired
autophagy might be one of the mechanisms by which T2D diabetes
accelerates cartilage degradation.
This study was supported by Instituto de Salud Carlos III- Ministerio de
Economía y Competitividad, Spain-CP11/00095 and Ph.D. Fellowship
SFRH/BD/78188/2011 from FCT Portugal and European Regional
Development Fund through COMPETE
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HSP70 INDUCED BY HIF-1 ALFA REGURATES ANABOLIC RESPONSES
IN CHONDROCYTES UNDER HYPOXIC CONDITIONS
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Resumen data
H J p value
Lactic acid production (mg/dl) 51.42±6.85 64.22±10.766 P<0.05
Glucose consumption (mg/dl) 27.28±12.1 35.75±14.36
02 consuption
Cr 9.975±3.07 36.925±4.81 P<0.05
Cro 5.375±1.64 14.05±2.83 P<0.05
Cru 17.9±11.88 57.175±11.03 P<0.05
RCR 3.13±1.29 4.26±1.25
UCR 1.68±0.67 1.53±0.27
% 0.31±0.21 0.4±0.04
Mitochondrial ROS production
(Mean Flurescence)
52.21±11.38 41.26±7.48 P<0.05
Induction of Apoptosis
(%Annexin-V cells)
7.35±3.78 4.69±1.68 P<0.05
Relative expression levels
MnSOD 0.53±0.04 0.707±0.10
IL-6 0.123±0.04 0.21±0.10
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A155Purpose: Articular cartilage is an avascular tissue. Chondrocytes in the
deepest layers of the articular cartilage are exposed to hypoxic con-
ditions, only 1 to 5% oxygen, but they can survive by adjusting their
metabolism. Hypoxia-inducible factor-1 alpha (HIF-1a) is one of the
most important transcription factors in maintaining proper cellular
functions under hypoxic conditions, and is essential for chondrogenesis.
To date, the HIF-1a-dependent anabolic pathways in chondrocytes
remain poorly understood. Among the genes regulated via the HIF-1a
pathway under hypoxic conditions, heat shock proteins (HSPs), which
act as cellular chaperones for proteins misfolded by cellular stress, are
highly conserved. We reported that HSP70 overexpression promoted
chondrocyte metabolism and protected chondrocytes from various
stress conditions. Nevertheless, the role of HSP70 under hypoxic con-
ditions remains unclear in articular chondrocytes. The aim of this study
is to analyze the expression of HIF-1a and HSP70 in articular chon-
drocytes under hypoxic conditions, and to investigate whether HSP70
implicate HIF-1a-dependent anabolic pathwas.
Methods: Primary rabbit chondrocytes were cultured as monolayers
under 20% (normoxia) or 1% (hypoxia) oxygen, or in medium containing
CoCl2, a chemical inducer of HIF-1a. Chondrocytes were transfected
with siRNA targeting HIF-1a (siHIF-1a) or HSP70 (siHSP70). The mRNA
levels of HIF-1a, HSP70, proteoglycan core protein (PG) and type II
collagen (Col II) were measured by quantitative real time RT-PCR. The
protein production were subjected to Western blotting for HIF-1a and
HSP70. Apoptosis was induced by sodium nitroprusside (SNP) dihydrate
that produces NO. Cell viability was assessed by lactate dehydrogenase
(LDH) release and tetrazolium salt-based assays. DNA fragmentation
was detected with a TUNEL staining.
Results: HIF-1a and HSP70 expression of the chondrocytes under
hypoxia or simulated hypoxia signiﬁcantly increased in mRNA and
protein levels as compared to those under normoxia. Although siHIF-1a
suppressed HSP70 expression of the cells incubated in hypoxia, siHSP70
did not affect HIF-1a. The levels of PG and Col II mRNA were highly
upregulated by hypoxia or HIF-1a inducer addition, whereas trans-
fection with siHIF-1a or siHSP70 signiﬁcantly attenuated the over-
expression of PG and Col II by hypoxia. Hypoxia decreased LDH release
from the cells, and siRNA against HIF-1a or HSP70 completely abrogated
this effect. These siRNAs also had strong inhibitory effects on the
enhanced cell proliferation under hypoxia. TUNEL-positive cells were
only 4.9 ± 0.8% of chondrocytes under hypoxia, a much lower per-
centage than observed under normoxia. These chondroprotective
effects, however, were almost completely cancelled out in the cells
transfected with siHIF-1a or siHSP70.
Conclusions: This study revealed that HSP70 expression in chon-
drocytes increased under hypoxia but it was abrogated by inactivation
of HIF-1a. These ﬁndings suggested that HIF-1a regulates hypoxia-
induced HSP70 expression in chondrocytes. The upregulated expression
of PG and Col II mRNAs in hypoxia was attenuated by HIF-1a or HSP70
gene suppression. This implied that ECM metabolism in chondrocytes
may be regulated via HIF-1a-induced HSP70. Moreover, suppression of
HIF-1a or HSP70 almost completely abolished the hypoxic effects on
LDH assay and tetrazolium salt-based assay, suggesting that HIF-1a-
induced HSP70 may develop chondrocyte viability via HIF-1a pathway.
The chondrocytes cultured in hypoxia were protected from NO-induced
apoptosis, but HIF-1a or HSP70 inhibition accelerated cell apoptosis.
These ﬁndings indicated that, under hypoxic conditions, the pathway
involving HIF-1a and HSP70 may participate in the chondrocyte pro-
tection from stress-induced cytotoxicity. In summary, HIF-1a-induced
HSP70 expression, at least partially, was positively correlated with HIF-
1a-dependent anabolic pathways.
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IN VITRO STUDIES SHOW THAT MTDNA HAPLOGROUP J AND H ARE
ASSOCIATED WITH DIFFERENT METABOLIC AND INFLAMMATORY
PROFILE. A POSSIBLE EXPLANATION TO OA PATHOGENESIS.
M. Fernandez-Moreno y, T. Hermida-Gomez y, A. Soto-Hermida y,
J. Fernandez-Tajes y, M. Vazqueaz-Mosquera y, E. Cortes-Pereira y,
S. Rela~no-Fernandez y, N. Oreiro-Villar y, C. Fernandez-Lopez y,
E. Gallardo-Perez z, R. Garesse z, I. Rego-Perez y, F. Blanco y. y INIBIC, La
Coru~na, Spain; zUAM-CSIC, Madrid, Spain
Purpose: Previous studies have showed the mtDNA haplogroup J are
associated with incidence and progression of OA. Transmitochondrial
cybrids are optimal cellular models to study mitochondrial biology and
function since they carry different mitochondrial variants with thesame nuclear background, excluding those variations from the nuclear
genome. The aim of this work is to test the real role of mtDNA hap-
logroups in cellular activity, using cybrids with mtDNA haplogroup H
and J.
Methods: Cybrids were developed using 143B.TK- Rho-0 cell line and
platelets from healthy (without OA) and OA donors with mtDNA hap-
logroups H and J. The metabolic status was evaluated by lactic acid
production and glucose consumption. OXPHOS function was evaluated
by O2 consumption using Oroboros® equipment. The mitochondrial
ROS production and percentage of apoptotic cells were measured by
Flow Cytometry using DHR 123 or and Annexin-V respectively. The
expression levels of OA-related genes, (MnSOD and IL-6), were eval-
uated by qRT-PCR. Appropriate statistical analyses were performed
with GraphPad Prism v5 and qBase software.
Results: J cybrids had higher lactic acid production than H (51.42 mg/ml
and 64.22 mg/ml p<0.05). Glucose consumption in No-OA cybrids
revealed similar levels but higher in J than in H cybrids. O2 consumption
reﬂected that mitochondrial respiratory function in H cybrids was sta-
tistic signiﬁcantly (p0.05) lower in all respiratory states (Cr, Cro and
Cru) than in J. Flux ratios did not show differences between cybrids,
respiratory control ratio (RCR¼Cru/Cro), uncoupling control ratio
(UCR¼Cru/Cr) and the percentage of respiratory capacity for ATP pro-
duction (%¼(Cr-Cro)/Cru) was similar in both cybrids. Mitochondrial
ROS production was lower in J than in H (41.26±7.48; 52.21±11.38,
p<0.05). Apoptosis showed 2-fold increase with Staurosporine (0.2 mM,
2 hours) in H cybrids (7.35±1.7) in comparison to J (4.69±1.6) (p<0.05).
Baseline expression of MnSOD was higher in cybrids J than in H the
same result was obtained for IL-6.
Experiments performed in cybrids obtained from OA platelets showed
the same behavior and conﬁrm the results explained before.
Conclusions: Cybrids described in this word have different metabolic
behavior, being J cybrids more efﬁcient using glucose via glycolysis. J
cybrids need more O2 consumption, produced less mitochondrial
reactive oxygen species and are less susceptible to undergo apoptosis
than H cybrids and. All these results showed that the mitochondria
obtained from healthy and OA donors had a different behaviour and also
these differences were increased by their own mitochondrial hap-
logroup. These data also offer a real rationale for why haplogroup J is
associated with lower risk of OA.232
A SMALL MOLECULE HARPAGOSIDE INHIBITS IL-1BETA-INDUCED
EXPRESSION OF IL-6 BY BLOCKING THE EXPRESSION OF C-FOS IN
PRIMARY HUMAN OSTEOARTHRITIS CHONDROCYTES
A. Haseeb, D. Leigh, T.M. Haqqi. Northeast Ohio Med. Univ., Rootstown,
OH, USA
Purpose: There is growing evidence in support of the involvement of IL-
6 in cartilage degradation in OA. A signiﬁcant correlation between IL-6
levels in serum as well as in synovial ﬂuid and OA severity has been
reported. IL-6 stimulate the expression of MMP-13 and inhibits the
expression of type II collagen. Harpagoside is a low molecular weight
natural compound isolated from the secondary roots of
